Novartis AG (JOBS) Licenses Vaccine Candidates from US Group, AlphaVax, Inc. for $20 Million

ZURICH, Dec 29 (Reuters) - Novartis AG will license a programme of vaccines from U.S. group AlphaVax against cytomegalovirus (CMV) infections, which can cause disability in newborn babies, the Swiss drugmaker said on Monday.